Edition:
United States

Hansa Medical AB (HMED.ST)

HMED.ST on Stockholm Stock Exchange

213.80SEK
12:00pm EDT
Change (% chg)

6.20kr (+2.99%)
Prev Close
207.60kr
Open
207.40kr
Day's High
214.00kr
Day's Low
206.40kr
Volume
115,387
Avg. Vol
129,164
52-wk High
290.00kr
52-wk Low
158.00kr

Chart for

About

Hansa Medical AB is a Sweden-based biopharmaceutical company with focus on immunomodulatory enzymes for treatment and prevention of rare and severe autoimmune conditions and transplant rejection. The Company’s operations consist of research and development for drug discovery. The Company conducts several projects, among which... (more)

Overall

Beta: 2.22
Market Cap(Mil.): kr7,916.44
Shares Outstanding(Mil.): 38.13
Dividend: --
Yield (%): --

Financials

  HMED.ST Industry Sector
P/E (TTM): -- 99.36 30.45
EPS (TTM): -5.18 -- --
ROI: -51.12 2.89 12.63
ROE: -51.73 1.65 14.82

BRIEF-Hansa Medical Q1 Operating Loss Widens To SEK 46.6 Million

* Q1 OPERATING LOSS SEK 46.6 MILLION VERSUS LOSS SEK 44.8 MILLION YEAR AGO

Apr 25 2018

BRIEF-Hansa Medical Appoints Søren Tulstrup New President And CEO

* SØREN TULSTRUP APPOINTED NEW PRESIDENT AND CEO OF HANSA MEDICAL

Mar 20 2018

Earnings vs. Estimates